Thymosin Alpha-1 (Ta1)

124.00 

Quantity

    Description

    Proper Handling
    • Reconstitute with Bacteriostatic Water
    • Specifications: Lyophilized powder. Purity (>98%) meets or exceeds U.S. Pharmacopeia (USP) regulations.
    • Storage: In lyophilized form, the peptide is stable for 2 years. Protect from light. Refrigerate and use within 45 days after opening or reconstituting.

    Thymosin Alpha-1 is a peptide naturally occurring in the thymus that has long been recognized for modifying, enhancing, and restoring immune function. Thymosin Alpha-1 has been utilized in the treatment of immunocompromised states and malignancies, as an enhancer of vaccine response, and as a means of curbing morbidity and mortality in sepsis and numerous infections. Studies have postulated that thymosin alpha 1 could help improve the outcome in severely ill corona virus disease 2019 patients by repairing damage caused by overactivation of lymphocytic immunity and how thymosin alpha 1 could prevent the excessive activation of T cells.

    Science-Backed Research

    • Eradicates bacteria, viruses, and fungi
    • Boosts the function of certain immune cells
    • Suppresses cancer and tumor growth
    • Accelerates the wound-healing process
    • Fights inflammation
    • Enhances antibody responses
    • Balances TH1/TH2

    Disclaimer: This peptide is for research and educational purposes only. It is not intended for diagnostic or therapeutic use without the guidance of a qualified healthcare professional.

    Description

    Proper Handling
    • Reconstitute with Bacteriostatic Water
    • Specifications: Lyophilized powder. Purity (>98%) meets or exceeds U.S. Pharmacopeia (USP) regulations.
    • Storage: In lyophilized form, the peptide is stable for 2 years. Protect from light. Refrigerate and use within 45 days after opening or reconstituting.

    Thymosin Alpha-1 is a peptide naturally occurring in the thymus that has long been recognized for modifying, enhancing, and restoring immune function. Thymosin Alpha-1 has been utilized in the treatment of immunocompromised states and malignancies, as an enhancer of vaccine response, and as a means of curbing morbidity and mortality in sepsis and numerous infections. Studies have postulated that thymosin alpha 1 could help improve the outcome in severely ill corona virus disease 2019 patients by repairing damage caused by overactivation of lymphocytic immunity and how thymosin alpha 1 could prevent the excessive activation of T cells.

    Science-Backed Research

    • Eradicates bacteria, viruses, and fungi
    • Boosts the function of certain immune cells
    • Suppresses cancer and tumor growth
    • Accelerates the wound-healing process
    • Fights inflammation
    • Enhances antibody responses
    • Balances TH1/TH2

    Disclaimer: This peptide is for research and educational purposes only. It is not intended for diagnostic or therapeutic use without the guidance of a qualified healthcare professional.